Biomerica is a biomedical technology company that develops, patents, manufactures and markets diagnostic and therapeutic products used at the point-of-care (physicians' offices and over-the-counter through drugstores and online) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. Co.'s diagnostic test kits are used to analyze blood, urine, nasal or fecal material from patients in the diagnosis of various diseases, food intolerances and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in small concentrations. We show 57 historical shares outstanding datapoints in our coverage of BMRA's shares outstanding history.
Understanding the changing numbers of BMRA shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like BMRA versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching BMRA by allowing them to research BMRA shares outstanding history
as well as any other stock in our coverage universe. |
Free BMRA Email Alerts:
Video: Shares Outstanding Importance
